Optimal remifentanil dosage for providing excellent intubating conditions when co‐administered with a single standard dose of propofol

Authors:

Abstract
Summary: This dose–response study aimed to determine the dose of remifentanil combined with propofol 2.5 mg.kg −1 which provided excellent intubation conditions in 95% of patients. Ninety premedicated female ASA 1 and 2 patients were randomly allocated to five remifentanil dose groups (1, 2, 3, 4 or 5 μg.kg −1 ). Induction of anaesthesia was performed with a blinded dose of remifentanil infused over 60 s simultaneously co‐administered with propofol 2.5 mg.kg −1 infused over 45 s. Tracheal intubation was attempted 150 s after the beginning of induction. Intubating conditions were assessed with the Copenhagen score. A probit analysis was performed to calculate the intubating efficient doses (IED) of remifentanil in 95% of patients (IED 95 ). Our data revealed that the IED 95 of remifentanil was 4.0 (95% CI: 3.4–5.6) μg.kg −1 , which was associated with a maximum decrease in heart rate and mean arterial pressure of < 30%, a finding which also applied to the other groups.

This publication has 33 references indexed in Scilit: